Brief: Verve Therapeutics Q2 EPS USD -0.59
Aug 08 (Reuters) - Verve Therapeutics Q2 collaboration revenue USD 6.692 million. * Q2 net income USD -49.805 million
Aug 08 (Reuters) - Verve Therapeutics Q2 collaboration revenue USD 6.692 million. * Q2 net income USD -49.805 million